RBM provider launches data quality oversight service for inspection readiness

By Melissa Fassbender

- Last updated on GMT

CluePoints provides Risk-Based Monitoring (RBM) solutions for clinical trial data quality. (Image: iStock/NicoElNino)
CluePoints provides Risk-Based Monitoring (RBM) solutions for clinical trial data quality. (Image: iStock/NicoElNino)
CluePoints has launched a new solution to help support clinical data quality improvement as the industry looks to mitigate fraud – both unintentional and malicious.

The company’s new RADAR service leverages statistical interrogation of clinical and operational study data to identify sites​ with anomalous, missing, or inconsistent data that may require inspection readiness action. 

Patrick Hughes, CluePoints Chief Commercial Officer told us the recent launch of CluePoints’ RADAR service helps support companies with clinical data quality improvement, as well as potentially helping companies identify the sites that the FDA might select for inspection after data is submitted.

This can also help sponsors plan for the own pre-submission audits and ensure quality of the data ahead of submission​,” explained Hughes.

The company has seen multiple issues with data quality​, some unintentional, such as miscalibrated equipment, or “site sloppiness,​” in which Hughes explained staff may not have been trained adequately or follow procedure.

More malicious causes do exist​,” Hughes added. These causes include tampering with data and fraud where there is an intention to cheat and falsify the data, for example, site staff filling out patient diaries or inventing patients.

In relation to all of these issues, the RADAR service identifies the typical patterns of data in a clinical trial and subsequently pinpoint exactly where sponsors should be focusing their attention and corrective action​,” explained Hughes.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars